Immunostimulation in recurrent respiratory tract infections therapy in children. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Immunostimulation in recurrent respiratory tract infections therapy in children.

Arch Immunol Ther Exp (Warsz). 1987;35(3):289-302. Unique Identifier : AIDSLINE MED/88182698
Prusek W; Jankowski A; Radomska G; Wieczorek E; Podwysocka M; Department of Pediatrics, Regional Hospital, Wroclaw.

Abstract: Selected immunologic parameters and effectivity of immunotherapy was evaluated in 117 children (12-month-10-year-1-old) suffering from recurrent respiratory tract infections. All the children displayed a profound depression of T lymphocytes number, which resemble the situation seen in AIDS patients. An increase of serum IgM concentration was also noted. Immunotherapy included treatment with the following preparations: TFX and Levamisol which stimulate T cell functions, Broncho-Vaxom which stimulates specific antibody production and a complex herb preparation PADMA showing undefined general stimulatory activity. Separate group of children was subjected to climatotherapy in Czerniawa Sanatorium and received no immunostimulants. All methods of treatment employed had beneficial effect. The highest percentage of positive results was obtained in children receiving TFX and Levamisol. In all groups under study, an elevation of T cells percentage was observed. This was especially evident in Levamisol treated patients. There was no correlation, however, between T cells number and clinical improvement.
Keywords: Adjuvants, Immunologic/THERAPEUTIC USE Child Child, Preschool Climate Female Human *Immunotherapy Infant Leukocyte Count Levamisole/THERAPEUTIC USE Male Plants, Medicinal Recurrence Respiratory Tract Infections/BLOOD/IMMUNOLOGY/*THERAPY T-Lymphocytes/IMMUNOLOGY Thymus Extracts/THERAPEUTIC USE JOURNAL ARTICLE

KWDadjuvants,immunologic/therapeuticusechildchild,preschoolclimatefemalehumanKWDimmunotherapyinfantleukocytecountlevamisole/therapeuticusemaleplants,medicinalrecurrencerespiratorytractinfections/blood/immunology/KWDtherapyt-lymphocytes/immunologythymusextracts/therapeuticusejournalarticle
880730
M8870441

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .